×
ADVERTISEMENT

SEPTEMBER 25, 2020

Novel Coronavirus Pain Signaling Disruption Leads to New Research

Preclinical studies based on SARS-CoV-2 observations point toward new drug targets

Research into the novel coronavirus isn’t just looking at halting infection.

As investigators continue learning more about how the virus interacts inside the body—specifically how its proteins may dull pain signaling—some are optimistic that new findings could open up avenues for innovative, nonopioid drug exploration.